ADIPEX-P Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Adipex-p, and when can generic versions of Adipex-p launch?
Adipex-p is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in ADIPEX-P is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adipex-p
A generic version of ADIPEX-P was approved as phentermine hydrochloride by ELITE LABS INC on May 30th, 1997.
Summary for ADIPEX-P
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,645 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ADIPEX-P |
| DailyMed Link: | ADIPEX-P at DailyMed |
Recent Clinical Trials for ADIPEX-P
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute on Drug Abuse (NIDA) | Phase 1 |
| University of Kentucky | Phase 1 |
| New York State Psychiatric Institute | Phase 4 |
Pharmacology for ADIPEX-P
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ADIPEX-P
US Patents and Regulatory Information for ADIPEX-P
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | ADIPEX-P | phentermine hydrochloride | CAPSULE;ORAL | 088023-001 | Aug 2, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Teva | ADIPEX-P | phentermine hydrochloride | TABLET;ORAL | 085128-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
